左心室扩张与右心室扩张功能之间的关系,在患有专利通道动脉的儿童中
Cole Miller1, William Anderson2, Joseph A Paolillo3
1Division of Pediatric Cardiology, Children's Hospital of Atlanta, Atlanta, GA, USA.
Annals of pediatric cardiology
|June 8, 2023
概括
在患有动脉管 (PDA) 的儿童中,左心室 (LV) 扩张没有影响右心室 (RV) 末腹压力 (RVEDP). 相反,RVEDP与RV的缩压有关.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管生理学心血管生理学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 心室与心室的相互作用对心血管健康至关重要.
- 左心室 (LV) 扩张对右心室 (RV) 扩张功能在儿科专利动脉通道 (PDA) 的影响仍未得到充分研究.
- 了解这些相互作用是管理复杂先天性心脏病的关键.
研究的目的:
- 为了研究LV扩张对RV扩张功能的影响,在患有PDA的儿科患者.
- 测试 LV 扩张通过 PDA 患者的心室-心室相互作用提高 RV 末端透气压 (RVEDP) 的假设.
主要方法:
- 对113名儿科患者 (6个月18岁) 进行过导管PDA关闭 (2010-2019) 的回顾性分析.
- 评估RVEDP,LV终端透气维度Z-score (LVEDD Z-score),RV静脉压,肺动脉/大动脉静脉压比,以及肺毛细血管压.
- 统计分析以确定变量之间的关联.
主要成果:
- RVEDP与RV静脉缩压 (P < 0.01),肺动脉/大动脉静脉压比 (P < 0.01),以及肺毛细血管压 (P < 0.01) 有积极关联.
- 没有发现RVEDP和LVEDD Z-score (P = 0.74) 之间的显著关联,表明LV扩张没有直接影响RVEDP.
- 中位数LVEDD Z-score为1.6,表明LV扩张存在于该队列中.
结论:
- 在患有PDA的儿科患者中,RVEDP与LV扩张没有显著的关联.
- 在这个人群中,RVEDP主要受到RV缩压和肺压的影响.
- 研究结果表明,通过LV扩张的心室-心室相互作用可能不是PDA中RV扩张功能障碍的主要驱动因素.
相关概念视频
Mitral Stenosis I: Introduction
19
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
19
Mitral Regurgitation I: Introduction
19
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
33
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
33
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26


